A Ligand for CD5 Is CD5

被引:51
|
作者
Brown, Marion H. [1 ]
Lacey, Erica [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
来源
JOURNAL OF IMMUNOLOGY | 2010年 / 185卷 / 10期
基金
英国医学研究理事会;
关键词
CYSTEINE-RICH DOMAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL SURFACE-IMMUNOGLOBULIN; POTENTIAL SELECTING LIGAND; RAT T-LYMPHOCYTES; SCAVENGER RECEPTOR; SRCR DOMAIN; MONOCLONAL-ANTIBODY; NATURAL-KILLER; B-CELLS;
D O I
10.4049/jimmunol.0903823
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recognition by scavenger receptor cysteine-rich domains on membrane proteins regulates innate and adaptive immune responses. Two receptors expressed primarily on T cells, CD5 and CD6, are linked genetically and are structurally similar, both containing three scavenger receptor cysteine-rich domains in their extracellular regions. A specific cell surface interaction for CD5 has been difficult to define at the molecular level because of the susceptibility of CD5 protein to denaturation. By using soluble CD5 purified at neutral pH to preserve biological activity, we show that CD5 mediates species-specific homophilic interactions. CD5 domain 1 only is involved in the interaction. CD5 mAbs that have functional effects in humans, rats, and mice block homophilic binding. Ag-specific responses by mouse T cells in vitro were increased when engagement of human CD5 domain 1 was inhibited by mutation or by IgG or Fab fragment from a CD5 mAb. This showed that homophilic binding results in productive engagement. Enhancement of polyclonal immune responses of rat lymph node cells by a Fab fragment from a CD5 mAb shown to block homophilic interactions provided evidence that the extracellular region of CD5 regulates inhibition in normal cells. These biochemical and in vitro functional assays provide evidence that the extracellular region of CD5 regulates immunity through species-specific homophilic interactions. The Journal of Immunology, 2010, 185: 6068-6074.
引用
收藏
页码:6068 / 6074
页数:7
相关论文
共 50 条
  • [41] Circulating soluble CD5 in atopic dermatitis
    Noh, GW
    Lee, KY
    MOLECULES AND CELLS, 1998, 8 (05) : 618 - 622
  • [42] Genomic organization of the human CD5 gene
    Olga Padilla
    Javier Calvo
    Josep Maria Vilà
    Mònica Arman
    Idoia Gimferrer
    Lourdes Places
    María Teresa Arias
    Miguel Angel Pujana
    Jordi Vives
    Francisco Lozano
    Immunogenetics, 2000, 51 : 993 - 1001
  • [43] CD5 primary immunodeficiency: Further characterization
    Weller, S
    Doefinger, R
    Wasserbauer, N
    Wells, JC
    Casanova, JL
    Hostoffer, RW
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S278 - S278
  • [44] In vitro and in vivo functional analysis of CD5(+) and CD5(-) B cells of autoimmune NZBxNZW F-1 mice
    Ye, YL
    Chuang, YH
    Chiang, BL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 106 (02): : 253 - 258
  • [45] IDENTIFICATION OF HYBRIDOMAS DERIVED FROM MOUSE CD5(+) B-LYMPHOCYTES BY FLUORESCENT STAINING FOR CYTOPLASMIC CD5 EXPRESSION
    SADIGH, S
    SCOTT, BB
    MAGEED, RA
    MALCOLM, A
    ANDREW, EM
    MAINI, RN
    IMMUNOLOGY, 1994, 81 (04) : 558 - 563
  • [46] ANALYSIS OF VH GENE-EXPRESSION IN CD5(+) AND CD5(-) B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
    MALOUM, K
    DAVI, F
    MAGNAC, C
    PRITSCH, O
    MCINTYRE, E
    VALENSI, F
    BINET, JL
    MERLEBERAL, H
    DIGHIERO, G
    BLOOD, 1995, 86 (10) : 3883 - 3890
  • [47] CD5 negative and CD5 positive splenic marginal B-cell lymphomas have differential cytogenetic patterns
    Gimeno, E
    Salido, M
    Solé, F
    Florensa, L
    Granada, I
    Domingo, A
    Woessner, S
    LEUKEMIA RESEARCH, 2005, 29 (08) : 981 - 982
  • [48] Mitigating the CD5 CAR-CD5 interaction enhances the functionality of CD5 CAR-T cells by alleviating the T-cell fratricide
    Ho, Lee Young
    Yu, Seung Rok
    Jeong, Hoon Jeong
    Lee, Hyeong Ji
    Cho, Hyeon Jeong
    Kim, Hyung Cheol
    CANCER RESEARCH, 2023, 83 (07)
  • [49] STRUCTURES OF SOME CADMIUM APATITES CD5(MO4)3X .1. DETERMINATION OF STRUCTURES OF CD5(VO4)3I, CD5(PO4)3BR, CD5(ASO4)3BR AND CD5(VO4)3BR
    SUDARSANAN, K
    YOUNG, RA
    WILSON, AJC
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1977, 33 (OCT): : 3136 - 3142
  • [50] CD5/CD19/CD23 chronic lymphocytosis
    Manteiga, R
    Munoz, L
    Nomdedeu, JF
    HAEMATOLOGICA, 1997, 82 (04) : 510 - 511